Keymed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Keymed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Keymed Today - Breaking & Trending Today

Keymed Biosciences Announces 2023 Annual Results and Business Updates

CHENGDU, China, March 26, 2024 /PRNewswire/ Keymed Biosciences Inc. (HKEX: 02162) today announced its 2023 Annual Results, along with recent . ....

Keymedbiosciences Inc , Keymedbiosciences Announces , Business Updates ,

Keymed Biosciences Announces 2023 Annual Results and Business Updates

Submitted a New Drug Application (NDA) of Stapokibart (CM310) for the treatment of moderate-to-severe AD in adults. The NDA was accepted by the China s NMPA. ....

United States , Bo Chen , Keymed Biosciences , Keymed Biosciences Inc , Prnewswire Keymed Biosciences Inc , American Society Of Hematology , Hong Kong Stock Exchange On , European Hematology Association , American Society Of Clinical Oncology , New Drug Application , Executive Director , Chief Executive Officer , American Society , Clinical Oncology , Hong Kong Stock Exchange ,

Keymed Biosciences Announces 2022 Annual Results: Efficiently Promotes Clinical Progress & Proactively Develops Global Strategic Collaboration

/PRNewswire/ Keymed Biosciences Inc. (HKEX: 02162) announced its 2022 annual results. Focused on unmet clinical needs, the Company continued to efficiently. ....

United States , Hong Kong , Keymed Bio , Biosciences Inc , Keymed Biosciences Inc , Team Of Talents Expanded Manufacturing Capabilities , Prnewswire Keymed Biosciences Inc , Hong Kong Stock Exchange On , Differentiated Pipelines , Initiated Phase , Orphan Drug Designation , Fast Track Designation , Expanded Manufacturing , Shenzhen Hong Kong Stock , Small Cap Index , Small Cap , Stock Code , Hong Kong Stock Exchange ,

Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901

/PRNewswire/ Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) and Lepu Biopharma Co., Ltd, (Stock Code: 02157.HK) today jointly announce a global. ....

United States , Lepu Biopharma , Keymed Biosciences , Bo Chen , Keymed Biosciences Inc , Hong Kong Stock Exchange On , Lepu Biopharma Co Ltd , Prnewswire Keymed Biosciences Inc , Biosciences Inc , Stock Code , Chief Executive Officer , Board Chairman , Senior Vice President , Biologics Engineering , Oncology Targeted Delivery , Hong Kong Stock Exchange ,

Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM

/PRNewswire/ Keymed Biosciences Inc. (Stock Code: 02162 HK) is pleased to announce that the latest data from the Phase Ia dose-escalation trial of CMG901. ....

United States , Keymed Biosciences , Department Of Medical Oncology , Keymed Biosciences Inc , Prnewswire Keymed Biosciences Inc , Hong Kong Stock Exchange On , Sun Yat Sen University Cancer Center , Stock Code , Cancers Symposium , American Society , Clinical Oncology , Medical Oncology , Sun Yat Sen University Cancer , Hong Kong Stock Exchange ,